Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hooper Anthony C
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   618,962    

Indirect Shares

   5,248      
Direct Value   $79,034,769    

Indirect Value

   $219,209      
Total Shares   624,210      
Total Value   $79,253,978      


Bristol-Myers Squibb Co $8,486,411 Amgen Inc $66,140,491 MannKind Corp $826,158 Beigene Ltd $3,581,710 Bristol-Myers Squibb Co $8,486,411 Amgen Inc $66,140,491 MannKind Corp $826,158 Beigene Ltd $3,581,710
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   58.4%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY SVP ComOps Pres USJap ... 2011-05-13 203,170 2011-05-13 5,248    Premium*  
            Amgen Inc AMGN EVP, Global Commercial... 2018-05-03 215,147 2011-10-27 0    Premium*  
            MannKind Corp MNKD Director 2024-02-04 176,153 0    Premium*  
            Beigene Ltd BGNE Director 2022-06-22 24,492 2021-06-16 0    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-03-04 4 D $26.43 $53,415 D/D (2,021) 160,673 0 -
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-03-06 4 D $26.43 $106,804 D/D (4,041) 165,349 0 -
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-03-07 4 D $26.31 $76,852 D/D (2,921) 162,428 0 -
BMY Bristol-Myers Squibb Co SVP ComOps Pres USJap Int   •       –      –    2011-05-13 4 D $28.80 $9,435,687 D/D (327,636) 203,170 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2013-03-02 4 D $92.58 $647,875 D/D (6,998) 67,823 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2013-03-13 4 D $91.75 $2,526,795 D/D (27,540) 93,060 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-03-02 4 D $124.02 $934,739 D/D (7,537) 90,865 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-03-12 4 D $124.27 $3,422,396 D/D (27,540) 116,210 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-04-27 4 D $111.41 $172,240 D/D (1,546) 114,664 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-01-28 4 D $158.89 $152,376 D/D (959) 113,952 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-03-02 4 D $157.72 $507,070 D/D (3,215) 115,334 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-03-11 4 D $153.58 $4,229,593 D/D (27,540) 195,148 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-03-27 4 D $160.55 $4,595,583 D/D (28,624) 166,909 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-04-27 4 D $167.91 $264,458 D/D (1,575) 165,334 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2016-01-28 4 D $150.47 $149,718 D/D (995) 164,339 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2016-01-31 4 D $152.73 $99,427 D/D (651) 163,962 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2016-03-25 4 D $149.24 $3,549,673 D/D (23,785) 185,855 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2016-04-27 4 D $162.85 $270,168 D/D (1,659) 184,196 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-01-28 4 D $157.16 $165,489 D/D (1,053) 188,571 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-01-30 4 D $157.16 $93,982 D/D (598) 187,973 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-01-31 4 D $154.43 $103,159 D/D (668) 187,305 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2017-03-24 4 D $166.04 $2,013,733 D/D (12,128) 198,482 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2018-01-30 4 D $198.00 $113,850 D/D (575) 203,134 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2018-01-31 4 D $191.27 $124,517 D/D (651) 202,483 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2018-03-23 4 D $176.08 $1,550,737 D/D (8,807) 211,522 0 -
  93  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us